1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Multi-step timeline: LOI due September 25, 2026; full application due February 12, 2027 (2026-2027 cycle). Deadline_found set to final submission date.
Alpha-1 Foundation Research Grant is sponsored by Alpha-1 Foundation. The Alpha-1 Foundation funds research efforts designed to improve the health of individuals with Alpha-1 Antitrypsin Deficiency (AATD), including lung and liver disease, with the ultimate goal of finding a cure.
While not directly related to ASS1 citrullinemia, it funds research into genetic conditions impacting liver disease and aims to understand basic biology and pathogenesis of rare genetic disorders.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Researchers and investigators in alpha-1 antitrypsin deficiency; pharmaceutical companies, biotechs, and industry are explicitly excluded. Confirm the full requirements in the official notice before applying.
The current listing shows up to $100,000/year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Alpha-1 Foundation Research Grant are due February 12, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Alpha-1 Foundation Research Grant is funded by Alpha-1 Foundation. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program